# Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

> **NCT00254462** · PHASE4 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 93 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** Placebo
- **BEHAVIORAL:** Parent Training

## Key facts

- **NCT ID:** NCT00254462
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10-01
- **Primary completion:** 2008-08-01
- **Final completion:** 2008-09-01
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2023-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00254462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00254462, "Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00254462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*